Add to ORKGNeuroleptic malignant syndrome is a rare complication when using neuroleptic drugs. We report the case of a patient with severe Parkinson's disease who developed neuroleptic malignant syndrome after withdrawal of his antiParkinsonian medication for elective coronary artery bypass grafting. Sodium dantrolene may be a therapeutic option in severe case
Multiple system atrophy (MSA) is a rare adult-onset neurodegenerative disease. Symptoms vary from au...
Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal complication associated with th...
Neuroleptic malignant syndrome is a potentially lethal condition of unclear cause seen in as many as...
The neuroleptic malignant syndrome is a rare and potentially lethal reaction which is usually associ...
Background: Neuroleptic malignant syndrome is a rare but life-threatening idiosyncratic complication...
Background: Neuroleptic malignant syndrome is a rare but life-threatening idiosyncratic complication...
Postoperative pulmonary complication(PPC) occur in 5-70% of caces in surgical patients and are accom...
Neuroleptic malignant syndrome is an uncommon condition characterised by hyperthermia, rigidity, alt...
Objectives: We report a fatal case of neuroleptic malignant-like syndrome, which occurred as a conse...
Abstract Background The neuroleptic malignant syndrome is an uncommon but dangerous complication cha...
Neuroleptic malignant syndrome is a neurological emergency caused by dysregulation of dopaminergic n...
Neuroleptic malignant syndrome (NMS) is an infrequent, but potentially life-threatening neurologic e...
Neuroleptic malignant syndrome (NMS) is a life-threatening reaction often related to neuroleptic dru...
Parkinson’s disease is a principal underlying disease of neuroleptic malignant syndrome (NMS) occurr...
Parkinsonism-hyperpyrexia syndrome (PHS), or neuroleptic malignant syndrome (NMS), is a neurophysiol...
Multiple system atrophy (MSA) is a rare adult-onset neurodegenerative disease. Symptoms vary from au...
Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal complication associated with th...
Neuroleptic malignant syndrome is a potentially lethal condition of unclear cause seen in as many as...
The neuroleptic malignant syndrome is a rare and potentially lethal reaction which is usually associ...
Background: Neuroleptic malignant syndrome is a rare but life-threatening idiosyncratic complication...
Background: Neuroleptic malignant syndrome is a rare but life-threatening idiosyncratic complication...
Postoperative pulmonary complication(PPC) occur in 5-70% of caces in surgical patients and are accom...
Neuroleptic malignant syndrome is an uncommon condition characterised by hyperthermia, rigidity, alt...
Objectives: We report a fatal case of neuroleptic malignant-like syndrome, which occurred as a conse...
Abstract Background The neuroleptic malignant syndrome is an uncommon but dangerous complication cha...
Neuroleptic malignant syndrome is a neurological emergency caused by dysregulation of dopaminergic n...
Neuroleptic malignant syndrome (NMS) is an infrequent, but potentially life-threatening neurologic e...
Neuroleptic malignant syndrome (NMS) is a life-threatening reaction often related to neuroleptic dru...
Parkinson’s disease is a principal underlying disease of neuroleptic malignant syndrome (NMS) occurr...
Parkinsonism-hyperpyrexia syndrome (PHS), or neuroleptic malignant syndrome (NMS), is a neurophysiol...
Multiple system atrophy (MSA) is a rare adult-onset neurodegenerative disease. Symptoms vary from au...
Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal complication associated with th...
Neuroleptic malignant syndrome is a potentially lethal condition of unclear cause seen in as many as...